Howard Lee

A target‐mediated drug disposition population pharmacokinetic model of GC1118, a novel anti‐EGFR antibody, in patients with solid tumors

Y. Bang, J. W. Kim, Keun-Wook Lee, 2020, Clinical and translational science.

A PROSPECTIVE COMPARISON OF MURINE MONOCLONAL CD‐3 (OKT3) ANTIBODY‐BASED AND EQUINE ANTITHYMOCYTE GLOBULIN‐BASED REJECTION PROPHYLAXIS IN CARDIAC TRANSPLANTATION

D. Renlund, M. Hammond, M. Bristow, 1989, Transplantation.

Phase 1 study of CWP232291 in patients with relapsed or refractory acute myeloid leukemia and myelodysplastic syndrome.

J. Cortes, J. Pagel, C. Jung, 2020, Blood advances.

A First‐in‐Human Phase I Study of GC1118, a Novel Anti‐Epidermal Growth Factor Receptor Antibody, in Patients with Advanced Solid Tumors

S. Hahn, Y. Bang, J. W. Kim, 2019, The oncologist.

A Randomized, Double-Blind, Placebo- and Active-Controlled, Escalating Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Profiles of Subcutaneous Eflapegrastim in Healthy Japanese and Caucasian Subjects

Seungjae Baek, S. Jhee, Howard Lee, 2022, Drugs in R&D.

A Phase 1b/2a Study of GC1118 with 5-Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) in Patients with Recurrent or Metastatic Colorectal Cancer

Sae-Won Han, Y. Cha, S. Beom, 2023, Cancer research and treatment.